| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
31,385 |
24,615 |
$907K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
12,872 |
11,108 |
$613K |
| T1015 |
Clinic visit/encounter, all-inclusive |
14,322 |
10,882 |
$578K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
15,948 |
12,131 |
$370K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,860 |
4,407 |
$234K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
4,171 |
3,677 |
$186K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
7,271 |
6,134 |
$150K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,846 |
2,555 |
$131K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,360 |
2,101 |
$119K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
8,345 |
6,874 |
$45K |
| 99050 |
|
3,220 |
2,574 |
$31K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,406 |
1,638 |
$25K |
| 99051 |
|
1,442 |
1,328 |
$23K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,988 |
1,734 |
$20K |
| 36416 |
|
8,831 |
7,327 |
$14K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,447 |
958 |
$11K |
| 90670 |
|
2,176 |
2,073 |
$9K |
| 90633 |
|
1,654 |
1,585 |
$9K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
712 |
631 |
$6K |
| 90651 |
|
1,057 |
1,022 |
$5K |
| 90723 |
|
1,714 |
1,602 |
$4K |
| 90686 |
|
3,423 |
3,253 |
$4K |
| 90710 |
|
917 |
873 |
$4K |
| 90671 |
|
1,030 |
940 |
$4K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
306 |
197 |
$3K |
| 92587 |
|
109 |
105 |
$3K |
| 90647 |
|
1,729 |
1,620 |
$2K |
| 90734 |
|
714 |
686 |
$1K |
| 90620 |
|
116 |
112 |
$924.82 |
| 99381 |
|
21 |
12 |
$847.05 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,093 |
2,385 |
$725.22 |
| 90696 |
|
214 |
208 |
$708.91 |
| 92015 |
Determination of refractive state |
39 |
38 |
$706.02 |
| 90681 |
|
553 |
512 |
$668.54 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
55 |
32 |
$412.14 |
| 90715 |
|
408 |
393 |
$376.45 |
| D1208 |
Topical application of fluoride, excluding varnish |
24 |
24 |
$360.00 |
| 99188 |
|
34 |
26 |
$339.00 |
| 90685 |
|
46 |
46 |
$144.65 |
| 83655 |
|
12 |
12 |
$129.12 |
| 80061 |
Lipid panel |
17 |
12 |
$119.64 |
| 90700 |
|
47 |
44 |
$99.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
18 |
12 |
$71.46 |
| 90619 |
|
135 |
131 |
$64.35 |
| 81003 |
|
115 |
80 |
$61.95 |
| 96127 |
|
15 |
15 |
$55.80 |
| 94760 |
|
155 |
144 |
$16.88 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
20 |
12 |
$0.96 |
| 90461 |
|
12 |
12 |
$0.00 |
| 90697 |
|
288 |
273 |
$0.00 |
| 90680 |
|
121 |
119 |
$0.00 |
| 90656 |
|
139 |
136 |
$0.00 |